@Riki_BCNA
I just wanted to update you that it looks like Roche have agreed in principle to include me in an access program where they pay every third Perjeta treatment. (My oncologist contacted them directly). Obviously this is still very expensive and won't be sustainable long term, but we are thinking we will try to self fund for a few months to see if it's working and hopefully in the mean time it will be considered for funding as a second or subsequent line of therapy for Stage IV HER2+, or I'll have some evidence to push my case. I will let you know how it goes, as I have to sign some paperwork tomorrow morning.
Best regards,
Keely
